tirzepatide 2024 Semaglutide & Tirzepatide: Leading GLP-1 Drug Sales in Real-world pharmacovigilance data for tirzepatide:

Its mild laxative properties should be considered in the context of GLP-1-related side effectsthis could be problematic for those with diarrhea but potentially beneficial for those experiencing constipation

Retatrutide, the next big GLP-1

Semaglutide can restore the decreased gut microbiota diversity in db/db mice and reverse the changes in specific bacterial levels induced by a high-fat diet (HFD) (Mao et al., 2024

Many patients at our South Florida clinic use this period for other supportive therapies

Most people report visible or physical changessuch as improved skin hydration or better joint comfortafter 8 to 12 weeks of consistent daily use